Effectdossier · gearchiveerd kwartaal
EOLS
Evolus, Inc. · Healthcare · Drug Manufacturers - Specialty & Generic
15Gevolgde houders
0Δ houders
14.12MGehouden aandelen
$130.04MGerapporteerde waarde
+1Nieuwe posities
−1Uitstappen
Momentum-inputs (vergelijkbare managers): breedte van houders 0.0% · aandelenstroom -3.9% · netto nieuwe posities 0.0% — formule
Alle eigendomscijfers: uitsluitend gevolgde 13F-managers, posities in gewone aandelen, rapportageperiode Q2 2025
Eigendom in de tijd
| Kwartaal | Houders | Δ | Aandelen | Gerapporteerde waarde | Nieuw | Uitstappen |
|---|---|---|---|---|---|---|
| Q2 2026 | 63 | +6 | 23.25M | $161.16M | +10 | −4 |
| Q1 2026 | 59 | -7 | 18.93M | $77.97M | +3 | −10 |
| Q4 2025 | 66 | -1 | 24.04M | $159.85M | — | −1 |
| Q3 2025 | 17 | -1 | 17.27M | $106.03M | — | −1 |
| Q2 2025 | 15 | 0 | 14.12M | $130.04M | +1 | −1 |
| Q1 2025 | 12 | +2 | 7.19M | $86.49M | +2 | — |
| Q4 2024 | 10 | -1 | 6.42M | $70.90M | — | −1 |
| Q3 2024 | 10 | 0 | 4.64M | $75.21M | +1 | −1 |
| Q2 2024 | 10 | — | 4.38M | $47.51M | — | — |
Wie het bezit · Q2 2025
| # | Manager | Aandelen | Δ aandelen | Waarde | Hun gewicht | Gehouden | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 2 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 3 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 4 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 5 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 6 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 7 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 8 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 9 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 10 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 11 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 12 | BlackRock ✦ (passief) | 4.18M | — | $38.54M | 0.0% | n/c | 1 | SEC ↗ |
| 13 | The Vanguard Group ✦ (passief) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 14 | The Vanguard Group ✦ (passief) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | The Vanguard Group ✦ (passief) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | The Vanguard Group ✦ (passief) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | The Vanguard Group ✦ (passief) | 3.32M | — | $30.56M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Millennium Management ✦ | 1.48M | +6.6% | $13.66M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 19 | State Street Global Advisors ✦ (passief) | 1.41M | +1.7% | $12.95M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 20 | Geode Capital Management ✦ (passief) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 21 | Geode Capital Management ✦ (passief) | 1.23M | -2.4% | $11.35M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 23 | D. E. Shaw & Co. ✦ | 957.74K | +9.2% | $8.82M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 24 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 25 | Citadel Advisors ✦ | 581.86K | +135.1% | $5.36M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 26 | Renaissance Technologies ✦ | 341.40K | +318.4% | $3.14M | 0.0% | ▲ Add | 2 | SEC ↗ |
| 27 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 28 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 29 | Wellington Management ✦ | 164.02K | +9.0% | $1.51M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 30 | Adage Capital Partners ✦ | 128.40K | -73.6% | $1.18M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 31 | Two Sigma Investments ✦ | 123.86K | -35.4% | $1.14M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 32 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 33 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 34 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 35 | AQR Capital Management ✦ | 71.27K | +6.8% | $656,350 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 36 | Marshall Wace ✦ | 67.85K | Nieuw | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 37 | Marshall Wace ✦ | 67.85K | Nieuw | $624,860 | 0.0% | New | 1 | SEC ↗ |
| 38 | T. Rowe Price ✦ | 56.32K | +3.1% | $519,000 | 0.0% | ▲ Add | 5 | SEC ↗ |
| 39 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 2.42K | — | $22,246 | 0.0% | n/c | 1 | SEC ↗ |
"Hun gewicht" = het aandeel van de positie in de gerapporteerde 13F-aandelenwaarde van die beheerder — de overtuigingsmaatstaf. ✦ = gecureerde beheerder.
Nieuwe kopers
| Marshall Wace | $624,860 | 0.0% |
| Marshall Wace | $624,860 | 0.0% |
Verlaten
| Soros Fund Management | $11.98M | was 0.3% |
Volledige marktcontext: over ALLE 13F-indieners (SEC gestructureerde data, Q1 2026): 146 houders, 45.63M aandelen, $187.01M gerapporteerd. Dit betreft een andere, oudere periode dan de bovenstaande cijfers van het gevolgde universum; beide worden nooit gecombineerd.
Vaak gezamenlijk in bezit
Wat de gevolgde houders van dit effect verder het vaakst bezitten — aantallen gedeeld eigendom, geen fundamentele relaties.
Herkomst: Eigendom op basis van geparseerde 13F common-stockposities (gevolgde universum, vergelijkbare sets voor wijzigingen); insider-rijen afkomstig van formulieren 3/4/5; belangen uit Schedules 13D/13G; elke indiening verwijst naar het origineel op SEC EDGAR.
Rapportageperiode: Q2 2025 ·
Methodologie ·
Verkrijg dit via de API